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Résumé en
anglais
Recent progress has allowed a more comprehensive study of the gut microbiota.
Gut microbiota helps in health maintenance and gut dysbiosis associates with
chronic metabolic diseases. Modulation of short-chain fatty acids and choline
bioavailability, lipoprotein lipase induction, alteration of bile acid profile,
endogenous alcohol production, or liver inflammation secondary to endotoxemia
result from gut dysbiosis. Modulation of the gut microbiota by pre/probiotics gives
promising results in animal, but needs to be evaluated in human before use in
clinical practice. Gut microbiota adds complexity to the pathophysiology of
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